Corient Private Wealth LLC

Position in FATE — Fate Therapeutics Inc

CIK 1948780 MIAMI, FL

Position in FATE

as of Jun 30, 2026 · filed Aug 27, 2026 Compact

Position Value

$179,590

+$143,752 QoQ

Shares Held

66,515

+122.7% QoQ

Ownership

0.056%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#63

of 156 holders

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 45% Shared 0% None 55%

Healthcare · as of Jun 30, 2026

Corient Private Wealth LLC holds $248,190,588 across 122 Biotechnology names. FATE ranks #92 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	103,755	$51,538,220
2	IONS	Ionis Pharmaceuticals Inc	196,661	$15,593,250
3	HALO	Halozyme Therapeutics, Inc.	187,166	$14,649,482
4	KRYS	Krystal Biotech, Inc.	30,558	$11,357,491
5	TECH	BIO-TECHNE Corp	119,590	$8,449,033
6	REGN	Regeneron Pharmaceuticals, Inc.	12,473	$7,777,414
7	ALNY	Alnylam Pharmaceuticals, Inc.	23,969	$7,215,387
8	CLDX	Celldex Therapeutics, Inc.	176,956	$6,584,532

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$179,590	66,515	+122.7%	Shares	Sole	2026-08-27
2026-03-31	$35,838	29,865	+0.1%	Shares	Sole	2026-05-15
2025-12-31	$29,233	29,830	+0.4%	Shares	Sole	2026-03-09
2025-06-30	$33,290	29,724	+0.3%	Shares	Sole	2025-09-26
2025-03-31	$23,422	29,649	0.0%	Shares	Sole	2025-05-14
2024-12-31	$48,920	29,649	0.0%	Shares	Sole	2025-02-10
2024-09-30	$103,771	29,649	0.0%	Shares	Sole	2024-11-12
2024-06-30	$97,248	29,649	-20.9%	Shares	Sole	2024-08-13
2024-03-31	$275,272	37,503	+26.5%	Shares	Sole	2024-05-09
2023-12-31	$110,887	29,649	-5.1%	Shares	Sole	2024-02-09
2023-09-30	$66,266	31,258	+0.2%	Shares	Sole	2023-11-03
2023-06-30	$148,440	31,185	-18.5%	Shares	Sole	2023-08-10
2023-03-31	$218,184	38,278	+24.9%	Shares	Sole	2023-05-15
2022-12-31	$309,157	30,640	—	Shares	Sole	2023-02-15
No filing history on record for this holder in this stock.